Haemodynamic management of severe sepsis: recommendations of the French Intensive Care Societies (SFAR/SRLF) Consensus Conference, 13 October 2005, Paris, France.
Critical care (London, England) · 2006-01-01 · Guideline / consensus
Abstract
We present a consensus report from the SFAR/SLRF (Société Française d'Anesthésie et de Réanimation/Société de Réanimation de Langue Française) Consensus Conference, held on 13 October 2005 in Paris, France. The consensus report made recommendations on five topics relevant to the treatment of circulatory failure in sepsis and its underlying rationale. These topics are as follows: therapeutic goals of haemodynamic support in sepsis; goals of fluid resuscitation (including transfusion); role of inotropes and vasoactive drugs; role of other treatments; and treatment strategy. This report is reproduced from a translation of the original in Annales Francaises of Anesthésie and Réanimation.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Blood products · Cardiovascular drugs · Fluids & blood · Vasopressors
Related articles
- Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical Trial. (JAMA, 2017)
- A randomized trial of protocol-based care for early septic shock. (N Engl J Med, 2014)
- Early Goal-Directed Therapy in Severe Sepsis and Septic Shock: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials. (J Intensive Care Med, 2018)
- Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock. (Health Technol Assess, 2015)
- The effect of early goal-directed therapy for treatment of severe sepsis or septic shock: A systemic review and meta-analysis. (J Crit Care, 2017)
- Early goal-directed and lactate-guided therapy in adult patients with severe sepsis and septic shock: a meta-analysis of randomized controlled trials. (J Transl Med, 2018)